The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future Prospects

The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future Prospects

Abstract Interleukin-17A (IL-17A) plays a pivotal role in many rheumatic immune-mediated inflammatory diseases. Targeting the IL-17 pathway has transformed the way psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are managed, with a number of IL-17A inhibitors now available for treating...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofia Ramiro, Georg Schett, Helena Marzo-Ortega, Wolfgang A. Schmidt
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Rheumatology and Therapy
Subjects:
Axial spondyloarthritis
Early treatment
Early diagnosis
Giant cell arteritis
IL-17A
IL-17A inhibition
Online Access:https://doi.org/10.1007/s40744-025-00754-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40744-025-00754-w

Similar Items